Vistagen Therapeutics, Inc. Common Stock
Symbol: VTGN (NASDAQ)
3.59
▲ (0.56%) 0.020
Company Description:
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Key Stats
- Today's Open: $3.57
- Today's High: $3.72
- Today's Low: $3.44
- Today's Volume: 242.76K
- Yesterday Close: $3.57
- Yesterday High: $3.6299
- Yesterday Low: $3.5
- Yesterday Volume: 169.57K
- Last Min Volume: 8
- Last Min High: $3.59
- Last Min Low: $3.59
- Last Min VWAP: $3.59
Company Profile
- Name: Vistagen Therapeutics, Inc. Common Stock
- Website: https://www.vistagen.com
- Listed Date: 2009-07-01
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001411685
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $109.53M
- Round Lot: 100
- Outstanding Shares: 30.68M
- Asset Type: CS
RECENT FILINGS FOR VTGN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-08 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-28 | DEFA14A | View |
| 2025-07-28 | DEF 14A | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 3 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
Latest News on VTGN